video thumbnail

Functions and Effects of Angiotensin II: A Mechanistic Review

Duration: 1:15:03

Write A New Comment

0 Comments

In this lecture, we will explore the physiological and pathological effects of Angiotensin II, a key effector of the renin-angiotensin-aldosterone system (RAAS). Based on Goodman & Gilman, we will examine three major domains of Angiotensin II action:
Altered Peripheral Resistance – including vasoconstriction and enhanced sympathetic activity 
Altered Renal Function – focusing on sodium reabsorption, aldosterone release, and renal hemodynamics
Altered Cardiovascular Structure – covering hypertrophy and remodeling effects

Objectives:

  • Understand the mechanisms by which Angiotensin II influences vascular tone, renal function, and cardiac structure
  • Identify the acute and chronic outcomes of Angiotensin II signaling
  • In the next lecture, we will link these effects to therapeutic targets of ACE inhibitors and ARBs

Functions and Effects of Angiotensin II

Brunton, Laurence; Knollman, Bjorn; Hilal-Dandan, Randa. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition (Goodman and Gilman"S the Pharmacological Basis of Therapeutics) (p. 1825). McGraw Hill LLC. Kindle Edition.

 

  • Understand the mechanisms by which Angiotensin II influences vascular tone, renal function, and cardiac structure
  • Identify the acute and chronic outcomes of Angiotensin II signaling
  • In the next lecture, we will link these effects to therapeutic targets of ACE inhibitors and ARBs

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

  • Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Dr. Mobeen Syed Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Pharma Mastery

Related Videos